The Effects of Weight Reduction With Orlistat vs. Placebo on Changes in Body Composition.

Trial Profile

The Effects of Weight Reduction With Orlistat vs. Placebo on Changes in Body Composition.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2013

At a glance

  • Drugs Orlistat (Primary)
  • Indications Obesity; Overweight
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 06 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.
    • 30 Jun 2011 Results published in Obesity
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top